Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Injectable COX-2-specific painkiller launched for the first time

May 2, 2002

Neotrofin fails to meet primary endpoint in Alzheimer's disease

April 30, 2002

New selective partial agonist at D4 receptors designed at German university

April 30, 2002

Inhibitors of JNKs useful for a wide range of conditions according to ARS

April 29, 2002

Cannabinoid receptor agonists reportedly useful for pain and Parkinson's disease

April 29, 2002

Orphan Medical licenses rights to butamben

April 29, 2002

GSK's naratriptan will be developed and marketed by Sumitomo in Japan

April 29, 2002

Egis and Servier select new anxiolytic development candidate

April 29, 2002

Advanced Medicine patents sodium channel modulators

April 26, 2002

Prefilled syringe presentation of Copaxone launched

April 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...